Comparison of COVID-19 laboratory diagnosis by commercial kits: Effectivity of RT-PCR to the RT-LAMP.
Coronavirus
Covid-19
LAMP-PCR
SARS-CoV-2
q-RT-PCR
Journal
Journal of medical virology
ISSN: 1096-9071
Titre abrégé: J Med Virol
Pays: United States
ID NLM: 7705876
Informations de publication
Date de publication:
05 2022
05 2022
Historique:
received:
14
12
2021
accepted:
27
12
2021
pubmed:
9
1
2022
medline:
24
3
2022
entrez:
8
1
2022
Statut:
ppublish
Résumé
Coronavirus disease 2019 or COVID-19 caused by novel coronavirus/severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 or 2019-nCoV) is an ongoing pandemic that has emerging global effects and requires rapid and reliable diagnostic testing. Quantitative reverse transcription-polymerase chain reaction (q-RT-PCR) is the gold standard method for SARS-CoV-2 detections. On the other hand, new approaches remedy the diagnosis difficulties gradually. Reverse transcription loop-mediated isothermal amplification (RT-LAMP) as one of these novel approaches may also contribute to faster and cheaper field-based testing. The present study was designed to evaluate this rapid screening diagnostic test that can give results in 30-45 min and to compare the effectiveness of LAMP to the q-RT-PCR. The 30 randomly chosen patient samples were generated by nasopharyngeal swabs with a portion of the SARS-CoV-2 nucleic sequence. The sample of quantification cycle (Cq) values was tested using RT-LAMP as well as by conventional q-RT-PCR. The patient samples were tested with four different kits (SENSObiz COVID-19 [SARS-CoV-2] LAMP Assay, the QIAseq DIRECT SARS-CoV-2 kit, Biospeedy SARS-CoV-2 Variant Plus kit, and CoVirion-CV19-2 SARS-CoV-2 OneStep RT-PCR kit) and two different PCR devices (GDS Rotor-Gene Q Thermocycler and Inovia Technologies GenX series). Based on 30 patient samples, the positive/negative ratio (P/N) was 30/0 as Biospeedy and Covirion (positivity 100%), 28/2 as Qiagen kit (positivity 93.3%) for the samples studied on the Inovia device while the same samples on the Rotor-Gene device were 30/0 as Biospeedy and Covirion (positivity 100%), 29/1 as Qiagen kit at the first day (96.7%). On the fifth day, the samples were studied in the Inovia device and the respective results were obtained: 27/3 as Biospeedy (positivity 90%), 16/14 as Qiagen (positivity 53.3%), 28/2 as Covirion kit (positivity 93.3%). When these samples were studied in the Rotor-Gene device, it was 29/1 in Biospeedy and Covirion (positivity 96.7%), 19/11 in the Qiagen kit (positivity 63.3%). When these samples were compared with the LAMP method it was found to be 19/11 (positivity 63.3%) on the first day and 18/12 (positivity 60%) on the fifth day. SARS-CoV-2 test studies will contribute to a proactive approach to the development of rapid diagnosis systems. The LAMP approach presents promising results to monitor exposed individuals and also improves screening efforts in potential ports of entry.
Identifiants
pubmed: 34997587
doi: 10.1002/jmv.27559
pmc: PMC9015626
doi:
Substances chimiques
RNA, Viral
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1998-2007Commentaires et corrections
Type : ErratumIn
Informations de copyright
© 2022 Wiley Periodicals LLC.
Références
Taştan C, Yurtsever B, SirKarakuŞ G, et al. SARS-CoV-2 isolation and propagation from turkish COVID-19 patients. Turkish J Biol 2020;44(3):192-202. doi:10.3906/biy-2004-113
Woloshin S, Schwartz LM. US food and drug administration approval of flibanserin. JAMA Intern. Med. 2016;176(4):439-442. doi:10.1001/jamainternmed.2016.0073
Zheng J. SARS-CoV-2: an emerging coronavirus that causes a global threat. Int J Biol Sci. 2020;16(no. 10):1678-1685. doi:10.7150/ijbs.45053
Zhai P, Ding Y, Wu X, Long J, Zhong Y, Li Y. The epidemiology, diagnosis and treatment of COVID-19. Int J Antimicrob Agents. 2020;55:(5):105955. doi:10.1016/j.ijantimicag.2020.105955
M. S.-D, P. J. S., Koehorst JJ, et al. Vitor AP martins dos santos MS-D and PJS. Global initiative on sharing all influenza data (GISAID). Phylogeny of SARS-like betacoronaviruses including novel coronavirus (nCoV). Oxford [Internet], Vol. 34, Oxford; 2017;1401-1403.
Taylor S, Landry CA, Paluszek MM, Fergus TA, McKay D, Asmundson GJG. COVID stress syndrome: concept, structure, and correlates. Depress Anxiety. 2020;37(8):706-714.
Andersen KG, Rambaut A, Lipkin WI, Holmes EC, Garry RF. A origem proximal do SARS-CoV-2. Nat Med. 2020;26(4):450-452.
World Health Organization. COVID-19: Weekly Epidemiological Update (3 November 2020). Accessed November 13, 2020. https://www.who.int/publications/m/item/weekly-epidemiological-update---3-november-2020
Yilmaz Gulec E, Cesur NP, Yesilyurt Fazlioğlu G, Kazezoğlu C. Effect of different storage conditions on COVID-19 RT-PCR results. J Med Virol. 2021;93:(12):6575. -6581. doi:10.1002/jmv.27204
Artik Y, Cesur NP, Kurtulmus MS, Mart Komurcu SZ, Kazezoglu C, Kocatas A. Clinic evaluation of the destrovir spray effectiveness in SARS-CoV-2 disease. Electron J Gen Med. 2022;19(1):emXXX.
Hatcher EL, Zhdanov SA, Bao Y, et al. Virus variation resource-improved response to emergent viral outbreaks. Nucleic Acids Res. 2017;45(D1):D482-D490.
Ehrhart J-C, Bennetau B, Renaud L, et al. A new immunosensor for breast cancer cell detection using antibody-coated long alkylsilane self-assembled monolayers in a parallel plate flow chamber. Biosens Bioelectron. 2008;24(3):467-474.
Hou H, Wang T, Zhang B, et al. Detection of IgM and IgG antibodies in patients with coronavirus disease 2019. Clin Transl Immunol. 2020;9(5):e1136.
Erdem Ö, Derin E, Sagdic K, Yilmaz EG, Inci F. Smart materials-integrated sensor technologies for COVID-19 diagnosis. Emergent Mater. 2021;4:(1):169. -185. doi:10.1007/s42247-020-00150-w
Tasrip NA, Mohd Desa MN, Khairil Mokhtar NF, et al. Rapid porcine detection in gelatin-based highly processed products using loop mediated isothermal amplification. J Food Sci Technol. 2021;58:1-10.
Corman VM, Landt O, Kaiser M, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 2020;25(3):2000045.
Singh R, Singh DP, Savargaonkar D, Singh OP, Bhatt RM, Valecha N. Evaluation of SYBR green I based visual loop-mediated isothermal amplification (LAMP) assay for genus and species-specific diagnosis of malaria in P. vivax and P. falciparum endemic regions. J Vector Borne Dis. 2017;54(1):54.
Varol N, Bulus Kirikkaya E. Afetler Karşısında Toplum Dirençliliği. Resilience. 2017;1:(1):1. -9. doi:10.32569/resilience.344784
Artik Y, Cesur N, Kenar L, Ortatatli M. Biological Disasters: In The First Quarter Of 2021 Covid-19 Overview. Afet ve Risk Dergisi. 2021;doi:10.35341/afet.977488
Komurcu SZM, Artik Y, Cesur NP, et al. The evaluation of potential global impact of the N501Y mutation in SARS-COV-2 positive patients. J Med Virol. 2021. doi:org/10.1002/jmv.27413
Xie X, Zhong Z, Zhao W, Zheng C, Wang F, Liu J. Chest CT for typical 2019-nCoV pneumonia: relationship to negative RT-PCR testing. Radiology. 2020;200343.
Liu X, Feng J, Zhang Q, et al. Analytical comparisons of SARS-COV-2 detection by qRT-PCR and ddPCR with multiple primer/probe sets. Emerg Microbes Infect. 2020;9(1):1175-1179.
Wu S, Liu X, Ye S, et al. Colorimetric isothermal nucleic acid detection of SARS-CoV-2 with dye combination. Heliyon. 2021;7(4):e06886.
Gonzalez JM, Shelton WJ, Díaz-Vallejo M, et al. Immunological assays for SARS-CoV-2: an analysis of available commercial tests to measure antigen and antibodies. MedRxiv. 2020.
Song J, El-Tholoth M, Li Y, Single-and Two-Stage, Closed-Tube, Point-of-Care, Molecular detection of SARS-CoV-2. Anal chem. 2021;93(38):13063-13071. http://doi.org/10.1021/acs.analchem.1c03016
Kitajima H, Tamura Y, Yoshida H, et al. Clinical COVID-19 diagnostic methods: comparison of reverse transcription loop-mediated isothermal amplification (RT-LAMP) and quantitative RT-PCR (qRT-PCR). J Clin Virol. 2021;139:104813.
Amaral C, Antunes W, Moe E. A molecular test based on RT-LAMP for rapid, sensitive and inexpensive colorimetric detection of SARS-CoV-2 in clinical samples. Sci Rep. 2021;11:16430.
Mautner L, Baillie CK, Herold HM, et al. Rapid point-of-care detection of SARS-CoV-2 using reverse transcription loop-mediated isothermal amplification (RT-LAMP). Virol J. 2020;17(1):1-14.
Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708-1720.
Lauer SA, Grantz KH, Bi Q, et al. The incubation period of coronavirus disease 2019 (CoVID-19) from publicly reported confirmed cases: estimation and application. Ann Intern Med. 2020;172(9):577-582.
Altındiş M, Elmas B, Kılıç Ü, Aslan FG, Küçükkara G, Köroğlu M. Grup A Streptokokların hızlı moleküler tanısında loop-mediated isothermal amplifi cation PCR (LAMP-PCR). J Biotechnol Strateg Heal Res. 2017;1(1):11-16.
Chaouch M. Loop-mediated isothermal amplification (LAMP): an effective molecular point-of-care technique for the rapid diagnosis of coronavirus SARS-CoV-2. Rev Med Virol. 2021;31:e2215.
Kashir J, Yaqinuddin A. Loop mediated isothermal amplification (LAMP) assays as a rapid diagnostic for COVID-19. Med Hypotheses. 2020;141:109786.
Lamb LE, Bartolone SN, Ward E, Chancellor MB. Rapid detection of novel coronavirus (COVID19) by reverse transcription-loop-mediated isothermal amplification. PLOS One. 2020;15:e0234682.